Discover 28 paid clinical trials in Hattiesburg, Mississippi. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 28
Active & Responsive
A Trial to Evaluate the Safety and Activity of Fruquintinib in Minority Populations With Advanced, Previously Treated Colorectal Cancer
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
for
Cancer, Metastatic, Cancer, Cancer of Pancreas, Cancer of Liver,
Location: Hattiesburg MS, Mobile AL, New Orleans LA,
Sponsor: Massive Bio, Inc.
Sex: All
Age: 0+
Code: NCT03452774
Recruiting
A Hip Flexion Feedback System for Exercise Monitoring in Individuals With Osteoarthritis and Obesity
for
Osteoarthritis, Knee, Obesity
Location: Hattiesburg MS
Sponsor: University of Southern Mississippi
Sex: All
Age: 30 - 70+
Code: NCT05997862
Phase1, Phase2, Recruiting
A Study Assessing Adverse Events and Disease Activity When Comparing Intravenously (IV) Infused ABBV-400 to Trifluridine and Tipiracil (LONSURF) Oral Tablets Plus IV Infused Bevacizumab in Adult Participants With c-Met Protein Above Cutoff Level Above Refractory Metastatic Colorectal Cancer
for
Metastatic Colorectal Cancer
Location: Hattiesburg MS, Germantown TN, Atlanta GA, Houston TX,
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT06614192
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Sacituzumab Tirumotecan (MK-2870) Versus Chemotherapy in Previously Treated Advanced or Metastatic Nonsquamous Non-small Cell Lung Cancer (NSCLC) With EGFR Mutations or Other Genomic Alterations (MK-2870-004)
Cancer, Early Detection of Cancer, Minimal Residual Disease
Location: Hattiesburg MS, Jackson MS, Mobile AL, New Orleans LA,
Sponsor: Caris Science, Inc.
Sex: All
Age: 18+
Code: NCT01499394
Recruiting
ELEMENT-MDS: A Study to Compare the Efficacy and Safety of Luspatercept in Participants With Myelodysplastic Syndrome (MDS) and Anemia Not Receiving Blood Transfusions
Study to Assess Change in Disease Activity and Adverse Events of Oral Venetoclax With Intravenous (IV) Obinutuzumab in Adult Participants With Recurring Chronic Lymphocytic Leukemia (CLL)
for
Chronic Lymphocytic Leukemia (CLL)
Location: Hattiesburg MS, Atlanta GA, Charlotte NC,
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT04895436
Phase2, Recruiting
A Study of Amivantamab Monotherapy and in Addition to Standard-of-Care Chemotherapy in Participants With Advanced or Metastatic Colorectal Cancer